Bcl-2 pathway inhibition in solid tumors: a review of clinical trials

Due to their key role in the pathogenesis of cancer through the regulation of apoptosis, the B-cell leukemia/lymphoma-2 (BCL-2) family proteins have been an attractive target for cancer therapy for the past decades. Throughout the years, many Bcl-2 family inhibitors have been developed, with Venetoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ploumaki, Ioanna, Triantafyllou, Efthymios, Koumprentziotis, Ioannis-Alexios, Karampinos, Konstantinos, Drougkas, Konstantinos, Karavolias, Ioannis, Trontzas, Ioannis, Kotteas, Elias A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203027/
https://www.ncbi.nlm.nih.gov/pubmed/36639602
http://dx.doi.org/10.1007/s12094-022-03070-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203027/
https://www.ncbi.nlm.nih.gov/pubmed/36639602
http://dx.doi.org/10.1007/s12094-022-03070-9

Ejemplares similares